E
COSCIENS Biopharma Inc. CSCI
$3.50 -$0.28-7.41% NASDAQ
Recommendation
Prev Close
$3.78
Volume
636
Avg Vol (90D)
19,148
Market Cap
$11.27M
Dividend & Yield
--
52-Week Range
$1.96 - $11.10
P/E (TTM)
--
EPS (TTM)
-$3.54
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn ...
4/14/2025 - GuruFocus
COSCIENS Biopharma (CSCI) Names Anna Biehn as New CEO CSCI Stock News
4/14/2025 - GuruFocus
Cosciens Biopharma appoints Biehn as CEO
4/14/2025 - TipRanks Financial Blog
Cosciens Biopharma appoints Biehn as CEO
4/14/2025 - The Fly
COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn ...
4/14/2025 - GuruFocus
COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn as Chief Executive Officer
4/14/2025 - Globe Newswire
COSCIENS Biopharma (NASDAQ:CSCI) Issues Quarterly Earnings Results
4/9/2025 - Ticker Report
COSCIENS Biopharma Reports Revenue Growth and Strategic Repositioning
4/9/2025 - TipRanks Financial Blog
COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and ...
4/9/2025 - GuruFocus
COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and ...
4/9/2025 - GuruFocus
COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update
4/9/2025 - Globe Newswire
COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order
4/2/2025 - GuruFocus
COSCIENS Biopharma Faces Management Cease Trade Order Amid Filing Delays
4/2/2025 - TipRanks Financial Blog
COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order
4/1/2025 - Globe Newswire
Why COSCIENS Biopharma Inc. (CSCI) Went Down On Thursday?
3/21/2025 - Insider Monkey
COSCIENS Biopharma Inc. Announces Possible Delay in Filing Year-End Reporting Documents
3/19/2025 - Newsfile Corp. - News Releases
COSCIENS Biopharma Inc. Announces Possible Delay in Filing Year-End Reporting Documents
3/19/2025 - GuruFocus
Cosciens Biopharma announces possible delay in filing 2024-end documents
3/19/2025 - TipRanks Financial Blog
Cosciens Biopharma announces possible delay in filing 2024-end documents
3/19/2025 - The Fly
COSCIENS Biopharma Inc. Announces Possible Delay in Filing Year-End Reporting Documents
3/19/2025 - Globe Newswire
COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a ...
3/13/2025 - GuruFocus
Cosciens Biopharma announces initiation of Phase 2a study for avenanthramides
3/13/2025 - The Fly
COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product
3/13/2025 - Globe Newswire
COSCIENS Biopharma halts investment in macimorelin; CMO to depart
12/23/2024 - Seeking Alpha - Healthcare
COSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline Prioritization
12/23/2024 - GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
$35.07M
Total Debt (Q)
$2.31M
Total Liabilities (Q)
$21.91M
Book Value Per Share (Q)
$4.19
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Wednesday, April 9, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Aug 11 and 15 (est)
Price History
Loading...
Beta
1.55
7-Day Total Return
11.64%
30-Day Total Return
14.11%
60-Day Total Return
28.68%
90-Day Total Return
31.09%
Year to Date Total Return
28.21%
1-Year Total Return
-56.41%
2-Year Total Return
-71.96%
3-Year Total Return
-86.37%
5-Year Total Return
-96.82%
52-week Low
Mar 13, 2025 - $1.96
52-week High
May 29, 2024 - $11.10
Valuation
Market Cap
$11.27M - Nano Cap
Enterprise Value
-$3.39M
Price/Sales (TTM)
1.54
Price/Book (Q)
0.90
Dividends and Shares
Shares Outstanding
3.14M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.cosciensbio.com
Phone Number
Address
222 Bay Street
Suite 3000 - PO Box 53
Toronto, ON M5K 1E7
Country
Canada
Year Founded
1990
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
COSCIENS Biopharma Inc., a life science company, engages in developing and commercializing products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany... more
NASDAQ 05/07/2025 1:37PM Eastern Quotes delayed